PCRX SCHEDULE 13D/A: Activist campaign
DOMA Perpetual Capital Management LLC and affiliated entities
Filed with the SEC on · accession 0001104659-26-115589
PCRX filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Oct 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.1% by the first close after the filing.
Summary of the filing
DOMA Perpetual Capital Management LLC and affiliated entities filed a joint filing agreement as part of an amended Schedule 13D regarding their position in Pacira BioSciences, Inc. The filing indicates coordinated ownership and potential activist involvement by the group.
Key details
How PCRX stock reacted
Close before
$36.35
Oct 12, 2026
First close after
-0.11%
$36.31
5 trading days
-0.03%
$36.34
Since filing
+0.25%
$36.44
✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PCRX?
Click hereFrequently asked questions
What did PCRX file with the SEC on Oct 13, 2026?
PCRX filed a SCHEDULE 13D/A (Activist campaign). DOMA Perpetual Capital Management LLC and affiliated entities filed a joint filing agreement as part of an amended Schedule 13D regarding their position in Pacira BioSciences, Inc. The filing indicates coordinated ownership and potential activist involvement by the group.
What does a activist campaign mean for PCRX stock?
A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did PCRX stock react to this filing?
PCRX closed at $36.35 before the filing and $36.31 on Oct 13, 2026 (-0.11%). Five trading days later: $36.34 (-0.03%).
Other PCRX SEC filings
- 8-K · AcquisitionNov 5, 2026
- 10-Q · Material agreementNov 5, 2026
- SC TO-T · Tender offerOct 30, 2026
- 8-K · SEC filingOct 8, 2026
- 8-K · SEC filingAug 4, 2026
- 10-Q · Executive departureAug 4, 2026
- 8-K · DivestitureJun 30, 2026
- 144 · Insider sale plannedJun 12, 2026
- 144 · Insider sale plannedJun 11, 2026
- 8-K · Board changeJun 11, 2026
Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days